NCT04227093View on ClinicalTrials.gov

Acetazolamide Add-On Therapy to OSA Surgery

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 22, 2020

Primary Completion Date

April 22, 2023

Study Completion Date

August 31, 2024

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Acetazolamide

Oral acetazolamide tablets of 250 mg taken twice daily.

DRUG

Placebo

Matching placebo tablets taken twice daily.

Trial Locations (1)

2650

Antwerp University Hospital, Edegem

All Listed Sponsors
lead

University Hospital, Antwerp

OTHER